Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
USD 1.43
(0.0%)
USD 1.43
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 94.18 Million | 85.3 Million | 54.28 Million | 65.76 Million | 21.2 Million | 52.78 Million |
| Net Income | 60.67 Million | 71.22 Million | 63.68 Million | 70.43 Million | 40.48 Million | 56.33 Million |
| Depreciation & Amortization | 15.98 Million | 11.64 Million | 8.29 Million | 7.97 Million | 7.53 Million | 4.12 Million |
| Deferred income taxes | -14.57 Million | -11.84 Million | -1.22 Million | -3.02 Million | -9.34 Million | -6.64 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 28.52 Million | -14.02 Million | -39.5 Million | -21.78 Million | -49.38 Million | -14.24 Million |
| Other non-cash items | 39.13 Million | 5.01 Million | 6.46 Million | -3.8 Million | 134.86 Million | 38.01 Million |
| Investing Cash Flow | -18.98 Million | -20.53 Million | -40.45 Million | -34.91 Million | -46.08 Million | -71.02 Million |
| Investments in PPE | -19.75 Million | -21.65 Million | -40.74 Million | -35.36 Million | -46.42 Million | -76.78 Million |
| Acquisitions | 769.73 Thousand | 1.12 Million | 287.47 Thousand | 453.13 Thousand | 336.63 Thousand | 5.76 Million |
| Investment purchases | -144.89 Million | -205.92 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.00 | -4.37 Million | 1.00 | 1.00 | 68.96 Thousand | - |
| Financing Cash Flow | -50.94 Million | -43.74 Million | -51.15 Million | 31.41 Million | 523.93 Thousand | 52.17 Million |
| Debt repayment | -5.24 Million | -25.17 Million | -25.43 Million | -21.7 Million | -7.97 Million | -58.97 Million |
| Dividends payments | -34.18 Million | -39.87 Million | -19.07 Million | - | - | - |
| Common Stock Repurchased | -8.45 Million | -51 Million | -7.58 Million | -774.93 Thousand | -4.81 Million | -6.8 Million |
| Common Stock Issuance | 1.74 Billion | 23.59 Million | 76.9 Million | 219.36 Thousand | - | - |
| Other Financing Activities | -1.1 Million | 48.7 Million | -75.95 Million | 57.4 Million | 357.71 Thousand | 117.95 Million |
| Accounts receivables | -14.41 Million | -10.56 Million | -11.94 Million | -37.92 Million | -78.33 Million | -29.96 Million |
| Accounts payables | 16.72 Million | 20.71 Million | -8.35 Million | -10.55 Million | 9.51 Million | 34.32 Million |
| Inventory | -5.89 Million | -22.28 Million | -11.08 Million | -11.42 Million | -19.05 Million | -20.91 Million |
| Other working capital | 32.11 Million | -1.89 Million | -8.12 Million | 38.11 Million | 38.5 Million | 2.31 Million |
| Cash at beginning of period | 77.1 Million | 61.58 Million | 105.58 Million | 48.87 Million | 71.83 Million | 55.85 Million |
| Cash at end of period | 98.36 Million | 77.1 Million | 61.58 Million | 105.58 Million | 48.87 Million | 71.83 Million |
| Capital Expenditure | -19.75 Million | -21.65 Million | -40.74 Million | -35.36 Million | -46.42 Million | -76.78 Million |
| Effect of forex changes on cash | -77.58 Million | -171.06 Million | -72.53 Million | -59.79 Million | 0.64 | -17.96 Million |
| Net cash flow / Change in cash | 21.26 Million | 15.51 Million | -43.99 Million | 56.71 Million | -22.95 Million | 15.98 Million |
| Free Cash Flow | 74.42 Million | 63.64 Million | 13.54 Million | 30.39 Million | -25.21 Million | -24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 660.06 Million | 34.43 Million | 22.45 Million | -6.79 Million | 60.67 Million | 21.26 Million |
| Depreciation & Amortization | 88.52 Million | 3.26 Million | 5.43 Million | 4.78 Million | 15.98 Million | 3.46 Million |
| Deferred income taxes | -5.25 Million | -1.81 Million | -7.2 Million | -3.38 Million | -14.57 Million | -3.34 Million |
| Stock-based compensation | - | 1530.43 | -11.28 Thousand | 4299.12 | - | 1090.01 |
| Change in working capital | 490.29 Million | -36.95 Million | -48.93 Million | 32.43 Million | 28.52 Million | 9.28 Million |
| Other non-cash items | 224.53 Million | 45.69 Million | 90.04 Million | -23.04 Million | 39.13 Million | -5.64 Million |
| Investing Cash Flow | -595.33 Million | -4.84 Million | -3.67 Million | -8.16 Million | -18.98 Million | -3.38 Million |
| Investments in PPE | -41.17 Million | -4.07 Million | -3.78 Million | -8.56 Million | -19.75 Million | -3.38 Million |
| Acquisitions | 100.64 Thousand | 183.24 Thousand | 48.45 Thousand | 406.11 Thousand | 769.73 Thousand | -1835.84 |
| Investment purchases | - | - | - | -8.53 Million | -144.89 Million | - |
| Sales/Maturities of investments | 1.96 Million | 7.08 Million | - | - | - | - |
| Other Investing Activities | -556.13 Million | -902.79 Thousand | 54.96 Thousand | 1.00 | 1.00 | -0.16 |
| Financing Cash Flow | -313.31 Million | -4.97 Million | -10.24 Million | -27.45 Million | -50.94 Million | -3.25 Million |
| Debt repayment | -131.99 Million | -4.21 Million | -4.51 Million | -10.58 Million | -5.24 Million | -6.72 Million |
| Dividends payments | -9.93 Million | -11.35 Million | -11.57 Million | -11.33 Million | -34.18 Million | -11.11 Million |
| Common Stock Repurchased | -671 Thousand | 2.22 Million | -2.46 Million | -5.33 Million | -8.45 Million | 2.59 Million |
| Common Stock Issuance | -34.05 Thousand | 1.76 Million | - | -193.93 Thousand | 1.74 Billion | 376.89 Million |
| Other Financing Activities | -248.97 Million | -256.89 Thousand | -11.35 Million | 58.88 | -1.1 Million | -364.9 Million |
| Accounts receivables | 251.44 Million | -14.27 Million | -64.58 Million | 28.51 Million | -14.41 Million | -1.24 Million |
| Accounts payables | 4.37 Million | -9.02 Million | 6.11 Million | -4.38 Million | 16.72 Million | 9.08 Million |
| Inventory | -67.19 Million | -3.27 Million | -9.33 Million | 15.21 Million | -5.89 Million | -11.55 Million |
| Other working capital | 306.05 Million | -10.37 Million | 18.87 Million | -6.9 Million | 32.11 Million | 13 Million |
| Cash at beginning of period | 1.23 Billion | 58.44 Million | 98.36 Million | 101.19 Million | 77.1 Million | 79.9 Million |
| Cash at end of period | 1.82 Billion | 56.44 Million | 58.44 Million | 98.36 Million | 98.36 Million | 101.19 Million |
| Capital Expenditure | -41.17 Million | -4.07 Million | -3.78 Million | -8.56 Million | -19.75 Million | -3.38 Million |
| Effect of forex changes on cash | 41.01 Million | 35.23 Million | -9.31 Million | 105.93 Million | -77.58 Million | -46.84 Million |
| Net cash flow / Change in cash | 595.77 Million | -2 Million | -39.92 Million | -2.83 Million | 21.26 Million | 21.29 Million |
| Free Cash Flow | 1.42 Billion | 7.45 Million | -20.66 Million | 25.18 Million | 74.42 Million | 28.56 Million |
7292
1473
ONFO
SMECF
BAM
0472